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Background and study aims: Terminal digit preference bias for “pleasing” numbers 
has been described in many areas of medicine. The aim of this study was to determine 
whether endoscopists, radiologists, and pathologists exhibit such bias when measuring 
colorectal polyp diameters. 
Methods: Colorectal polyp diameters measured at endoscopy, computed tomographic 
colonography (CTC), and histopathology were collated from a colorectal cancer 
screening program and two parallel multicenter randomized trials. Smoothing models 
were fitted to the data to estimate the expected number of polyps at 1-mm increments, 
assuming no systematic measurement bias. The difference between the expected and 
observed numbers of polyps was calculated for each terminal digit using statistical 
modeling. The impact of measurement bias on per-patient detection rates of polyps 
≥10 mm was estimated for each modality.   
Results: A total of 92 124 individual polyps were measured by endoscopy (91 670 
screening and 454 from trials), 2 385 polyps were measured by CTC (1664 screening, 
721 trials), and 79 272 were measured by histopathology (78 783 screening, 489 
trials). Clustering of polyp diameter measurements at 5-mm intervals was 
demonstrated for all modalities, both in the screening program and the trials. The 
statistical models estimated that per-patient detection rates of polyps ≥10 mm were 
over-inflated by 2.4% for endoscopy, 3.1% for CTC, and 3.3% for histopathology in 
the screening program, with similar trends in the randomized trials. 
Conclusion: Endoscopists, radiologists, and pathologists all exhibit terminal digit 
preference when measuring colorectal polyps. This will bias trial data, referral rates 
for further testing, adenoma surveillance regimens, and comparisons between tests. 
Introduction 
Timely endoscopic polypectomy prevents colorectal cancer; meta-analysis [1] of 
randomized trials [2–5] confirms that both incidence and mortality are reduced by 
screening. Following an index colonoscopy, whether performed in a screening or 
symptomatic setting, patients may be categorized according to their subsequent risk of 
colorectal neoplasia, which depends on the number and maximal diameter of 
adenomas measured at the index colonoscopy [6,7]. Any bias in the measurement of 
polyp diameter will influence risk categorization and hence the requirement for 
surveillance colonoscopy. 
Measuring polyp diameter is also important in other disciplines. Computed 
tomographic colonography (CTC) is a sensitive technique for the detection of 
colorectal polyps [8] and cancers [9]. CTC can estimate the size, number, and 
morphology of polyps, all factors that are related to the risk of advanced histology 
[10], thereby guiding referral for subsequent colonoscopy. Such referral largely 
depends on polyp diameter and number [11]. However, phantom [12] and clinical 
studies [13] have shown that CTC may not assess diameter accurately, and any 
measurement bias will affect referral rates to colonoscopy. Histopathologists also 
measure colorectal polyps, most commonly providing a reference measurement of the 
adenomatous portion of a polypectomy specimen [14], thereby also impacting on 
surveillance schedules if biased. 
As the importance of specific diameter thresholds are well known to endoscopists, 
radiologists, and pathologists, it is possible that this knowledge might bias estimates 
of maximal polyp diameter. For example, if 9-mm polyps are up-rated to 10 mm 
consistently, advanced adenoma rates will be overestimated, as this diameter 
threshold partly defines an adenoma as “advanced” [15]. Because detection rates of 
adenomas ≥10 mm are often used to compare screening modalities [16,17], if one 
modality is subject to bias more frequently than the others, an artificial difference in 
detection rates of adenomas ≥10 mm will be reported whereas, in reality, this may be 
due to error. If such bias exists, it will likely be manifest as “terminal digit 
preference.” This describes over-representation of certain numbers, usually digits 
ending with 5 or 0, and has been reported in studies of hypertension [18], renal 
cancers [19], and emergency department waiting times [20].  
The aim of the current study was to determine whether terminal digit preference 
occurred in measurements of maximal polyp diameter by three groups of observers: 
(1) colonoscopists measuring polyps in vivo; (2) radiologists reporting CTC; and (3) 
histopathologists measuring polyps ex vivo. Both symptomatic and screening patient 
populations were examined.  
Materials and methods 
A waiver to publish nonidentifiable data was obtained from the University College 
London / University College London Hospitals Joint Research Office. 
Data sources 
Participants were included from centrally held data from the English National Health 
Service Bowel Cancer Screening Programme (“BCSP cases”), and two randomized 
controlled trials of symptomatic patients [21,22] (“RCT cases”). The BCSP is a 
national screening program of adults aged 60–74 years, using guaiac fecal occult 
blood test (gFOBT), followed by colonoscopy for those testing positive [23]. CTC is 
used when colonoscopy is incomplete or judged unsuitable (e.g. due to co-morbidity) 
as per international consensus recommendations [24,25]. The RCTs were parallel, 
multicenter, randomized trials of barium enema vs. CTC and colonoscopy vs. CTC for 
diagnosis of colorectal cancer and polyps ≥10 mm in symptomatic patients. The 
primary outcomes of both trials have been published [21,22]. 
Endoscopy, CTC, and pathology 
Endoscopists working within the BCSP must have completed >1000 colonoscopies 
(including >150 in the previous year), passed a written multiple-choice question 
examination, and been assessed during two peer-observed colonoscopies [26]. Polyp 
diameter is usually judged in comparison to open biopsy forceps or an endoscopic 
snare, measured to the nearest millimeter. Sedoanalgesia is administered in 
approximately 90% of cases, according to endoscopist preference and patient 
requirements.  
The CTC technique within the BCSP requires multidetector-row computed 
tomography (CT) at a slice thickness of 1–3 mm, dual patient positioning, gas 
insufflations, and a colonography workstation [27]. Oral contrast fecal tagging and 
administration of antispasmodics are recommended (and now mandatory).  
Pathologists are requested to record the absolute diameter of nonadenomatous polyps 
and the maximal diameter of the adenomatous portion for adenomas, using a dome 
magnifier or microscope micrometer scale, to the nearest millimeter. Large lesions 
that cannot be accommodated are measured using a ruler and the formalin-fixed 
specimen to the nearest millimeter. 
The RCTs were conducted at 21 hospitals and included 217 accredited endoscopists. 
Polyp diameters were measured according to routine local practice, entailing 
judgement of size in comparison to biopsy forceps. CTC examinations required full 
bowel purgation, multidetector-row CT at a minimum collimation of 2.5 mm, dual 
patient positioning, colonic gas insufflations, and a colonography workstation. CTC 
interpretation was by 41 consultant radiologists with experience of CTC, including a 
2-day training course. Polyp measurement was discussed during training, and 
radiologists were asked to measure the long axis of all suspected polyps using 
electronic calipers, using multiplanar reformatting and a suitable CT window. 
Maximal polyp diameters for both CTC and colonoscopy were recorded on a case 
report form, to the nearest millimeter. 
Data selection 
Polyp diameters for BCSP cases were extracted from the program database for all 
screenees undergoing colonoscopy as their first-line test following positive gFOBT 
from January 2011 to December 2012. For CTC, we selected all patients who 
underwent CTC as their first-line test to investigate positive gFOBT from April 2006 
to March 2013, and who had a polyp detected. 
The RCT database was searched by a statistician, who identified and extracted all 
polyp measurements (at endoscopy, CTC, or histopathology) for all patients included 
in either trial. If the same polyp was visualized at multiple endoscopic examinations 
(e.g. diagnostic endoscopy followed by a repeat examination for polypectomy), all 
measurements were included, on the basis that each individual measurement might be 
subject to terminal digit preference. Data were collated in Microsoft Excel 2011 for 
Mac (Microsoft Corp., Redmond, Washington, USA) and analyzed using R version 
3.0.1 (R Foundation for Statistical Computing, Vienna, Austria).  
Statistical analysis 
Patients may have more than one polyp, and measurements of polyp diameter may be 
correlated within individuals (i.e. clustered). To account for this, we conducted a 
cluster bootstrap analysis, generating 2000 replicates by sampling with replacement 
from the highest level (patient) and without replacement from the lower level (polyp), 
as this is preferred to sampling with replacement at all levels [28]. The 95% 
confidence intervals were calculated using the percentile method. Subsequently, to 
estimate over-representation of a particular terminal digit, we required assumptions 
regarding the true distribution of polyp diameters; this is unknown, and nonlinear. 
Small polyps are more frequent than large polyps, so we expect more polyp diameters 
with terminal digits of 1 or 2 than 8 or 9. We used two previously published methods 
of estimating distributions subject to digit preference [29,30]. Camarda et al. [29] 
developed a composite link model to estimate the probability of misreported data and 
reassign these to a neighboring category, thereby providing an estimate of the 
underlying distribution. The Wang et al. method [30] smooths the observed 
distribution of polyp sizes by using a kernel density estimator. Both methods were 
implemented in R version 3.0.1 using code provided by each method’s lead author 
(Camarda: https://sites.google.com/site/carlogiovannicamarda/r-stuff/digit-preference-
model; Wang: bda package [31]). We were unable to apply these methods to each 
individual bootstrap replicate owing to computational demands; therefore, these 
analyses were conducted on the original dataset. 
Having estimated the underlying distribution of polyp sizes without digit preference, 
we compared this to the observed number of polyps at 1-mm diameter increments, 
pooled across each terminal digit (e.g. 2 mm, 12 mm, 22 mm – terminal digit of 2). 
The difference between the observed number of polyps at each terminal digit and that 
predicted by the models was taken as an estimate of the number of “re-allocated” 
polyps (i.e. moved to a different size measurement). This was then converted to a 
percentage to allow comparison between endoscopy, CTC, and histopathology. 
Because of the importance of the 10-mm diameter threshold, we calculated the effect 
that bias might have on detection rates of polyps ≥10 mm on a per-patient basis. The 
analysis was restricted to polyps nearing 10 mm, because digit preference bias at 
larger sizes rarely alters clinical management. We specifically focused on polyps 
within 3 mm of the 10-mm threshold (i.e. 7 mm to 13 mm) as we judged that larger 
rounding errors purely due to digit preference were implausible. For example, if 1000 
polyps were recorded as measuring 10 mm, but no polyps measured 7 mm, 8 mm, 
9 mm, 11 mm, 12 mm, or 13 mm, we assumed that some of these 1000 polyps would, 
in reality, have measured less than 10 mm and some would have measured more. We 
used the Camarda et al. and Wang et al. models to predict the correct distribution of 
diameters of these 1000 polyps, and compared them to the observed number. 
Statistical significance testing was not performed because the very large number of 
polyps included meant that even small deviations from the model were highly 
significant. We did not attempt to test which modality was most “accurate,” or 
agreement between the three methods of polyp measurement, as our interest was to 
document and quantify digit preference bias, rather than polyp measurement accuracy 
against a reference standard. Furthermore, we were unable to reliably match all polyps 
between all three modalities, rendering such a comparison impossible. Finally, we 
conducted an exploratory analysis, treating adenomas and nonadenomas separately, 
on the basis that the former are of greater biological significance and therefore any 
bias carries greater clinical importance. 
Results 
Screening program cases 
Endoscopic measurements 
Polyp diameters were available for 91 670 polyps in 36 850 individuals, with a mean 
diameter of 6.6 mm (range 1–200 mm). In total, 67 453 polyps (73.6%) were sessile, 
21 890 (23.9%) were pedunculated, and 2327 (2.5%) were flat. Diameter distribution 
is shown in Fig. 1a, with clusters evident at 5-mm intervals. Positive deviation from 
the fitted model of polyp diameters was substantially greater for the terminal digit of 0 
(i.e. multiples of 10 mm) than for all other sizes (Fig. 1b [Camarda model] and Fig. 1c 
[Wang model]). A similar, but less marked effect was present for polyp diameters 
with a terminal digit of 5 mm. Approximately 10% of all re-allocated polyp diameters 
occurred for a terminal digit of zero (estimate by Camarda method 10.1%; Wang 
method 9.5%), and approximately 7% of re-allocation occurred for a terminal digit of 
5 (Camarda estimate 6.9%, Wang method 7.3%). In contrast, there was a relative 
deficiency of polyps measured as having a diameter with a terminal digit of 1 
(Camarda estimate –6.5%, Wang estimate –7.9%) or of 9 (Camarda estimate –4.4%, 
Wang estimate –5.7%). There was a tendency for the effect to be of greater magnitude 
for adenomatous vs. nonadenomatous polyps (Fig. e2a,b, available online). 
CTC measurements 
Measurements were available for 1664 polyps in 892 individuals. Mean diameter was 
9.5 mm (range 1–91 mm). In total, 1108 polyps (66.6%) were sessile, 494 (29.7%) 
were pedunculated, and 62 (3.7%) were flat. Diameter distribution is shown in Fig. 
3a, with clusters at 5-mm intervals, similarly to the endoscopy data. Deviation from 
the fitted model of polyp diameters was substantially greater for the terminal digit 0 
(i.e. multiples of 10 mm) than for all other sizes. There was a small excess of polyps 
with a terminal digit measurement of 5, and a relative deficiency of polyps with a 
maximum diameter ending in either 1 or 9 (Fig. 3b,c). Approximately 8% of all re-
allocated polyp diameters occurred for a terminal digit of 0 (Camarda estimate 8.0%, 
Wang estimate 8.3%), and approximately 5% of re-allocation occurred for a terminal 
digit of 5 (Camarda estimate 5.1%, Wang estimate 5.3%). 
Histopathological measurements 
Diameters were available for 78 783 polyps in 33 891 individuals (fewer than 
endoscopy because of incomplete data entry and polyp nonretrieval). Mean polyp 
diameter was 6.4 mm (range 1–190 mm). Once again, diameters clustered at 5-mm 
intervals (Fig. 4a), with an excess of polyps with diameters ending in 0 
(approximately 4.0% of re-allocated polyps by both Camarda and Wang methods) or 
5 (Camarda estimate 2.9%, Wang estimate 3.5%), and relative under-representation of 
polyps with a diameter measurement ending in 1 or 9 mm (Fig. 4b,c). As for 
endoscopy, the effect was more marked for adenomatous polyps (Fig. e5a,b, available 
online). 
Estimated impact on per-patient detection rates of polyps ≥10 mm 
Of the 36 850 screenees with polyps diagnosed endoscopically, 15 952 (43.3%) had at 
least one polyp measured as ≥10 mm. Assuming the fitted models represent the true 
distribution of polyps, the Camarda method suggests that only 15 223 (41.3%) 
patients would truly have polyps ≥10 mm. The Wang method estimated this figure to 
be 14 924 patients (40.5%). The average difference between the observed number of 
polyps ≥10 mm and the number derived by the two methods was –2.4% (i.e. we 
estimate that 2.4% of all patients undergoing endoscopy were erroneously diagnosed 
with polyps ≥10 mm as a result of digit preference). For CTC, of the 892 screenees 
with polyps diagnosed, 483 (54.1%) had one or more polyps ≥10 mm. The Carmarda 
model suggests that this figure would be 463 (51.9%) without digit preference bias, 
and the Wang method estimates the true figure to be 447 (50.1%); the average 
difference was -3.1%. Finally, for histological measurement, 14 282 of 33 891 
(42.1%) screenees had polyps ≥10 mm. This figure would fall to 13 653 (40.3%) 
under the assumption of a smooth distribution of polyp diameters using the Camarda 
method, and to 12 660 (37.4%) using that of Wang – a mean difference of -3.3% 
(Table 1). 
RCT cases 
Endoscopic measurements 
Data were available for 454 polyps, of which 329 had diameters measured. Mean 
diameter was 10.2 mm (range 1–115mm). Similarly to the screening data, clustering 
at 5-mm intervals was evident (Fig. 6a), particularly for terminal digits of 0 (Fig. 6b), 
with approximately 24% (both Camarda and Wang methods) of re-allocation 
occurring for polyps with a maximum diameter of a multiple of 10 mm.  
CTC measurements 
A total of 721 polyps were documented, of which 680 had diameters recorded: 41 
polyps had either no recorded diameter or a size category only (<5 mm, 5–9 mm, or 
≥10 mm). Mean diameter was 13.6 mm (range 2–110 mm), and again showed 
clustering at 5-mm intervals (Fig. 7a). Approximately 18.3% (Camarda) to 22.4% 
(Wang) of re-allocation occurred for polyps with a maximal diameter of a multiple of 
10 mm (Fig. 7b,c). 
Histopathological measurements 
A total of 489 polyps were documented, 244 of which had diameters recorded (mean 
18.8 mm, range 1–230 mm). As for other modalities, the number of polyps at 
multiples of 5 mm was greater than expected (Fig. 8a). Re-allocated polyps were 
considerably more common for terminal digits of 5 (Camarda estimate 17.0%, Wang 
estimate 19.7%) or 0 (Camarda estimate 19.4%, Wang estimate 20.9%) (Fig. 8b,c).  
Estimated impact on per-patient detection rates of polyps ≥10 mm 
Endoscopic data were available for 169 patients, of whom 81 (47.9%) had polyps 
≥10 mm. No patient had either a 9 mm or an 11 mm polyp recorded as their largest 
lesion; 24 patients had polyps measuring precisely 10 mm. The two models predicted 
that 73 patients (43.2% Camarda method) or 72 patients (42.6% Wang method) would 
have polyps ≥10 mm, corresponding to a mean difference of -5.0% from the observed 
percentage. A total of 333 patients had their largest polyp diameter recorded to 1-mm 
precision at CTC, of whom 192 (57.7%) had their largest polyp measured as ≥10 mm, 
whereas the Camarda model predicted that this figure would be 194 (58.3%) without 
digit preference. The Wang model gave a very similar estimate of 191 patients 
(57.4%); the mean difference was 0.26%. For pathology, 162 patients had 
pathological diameters recorded; 102 (63.0%) harbored polyps of ≥10 mm. This 
figure dropped to 98 patients (60.5%) by the Camarda method and to 96 patients 
(59.3%) when using the Wang estimate (Table 1) – an average difference of -3.1% 
from the observed value. 
Discussion 
This study demonstrated that measurement of polyps by endoscopists, radiologists, 
and histopathologists, in both screening and symptomatic practice, is subject to 
terminal digit preference bias. The effect is sizeable and apparent across all polyp 
diameters. Our data suggest that terminal digit preference may increase the proportion 
of patients with polyps ≥10 mm measured at CTC by up to 3%, increasing the referral 
rate for colonoscopy inappropriately. Furthermore, the same phenomenon occurs at 
both colonoscopy and histopathology, with an estimated 2%–5% of patients 
erroneously diagnosed with polyps ≥10 mm, and therefore potentially subjected to 
unnecessarily intensive colonoscopic surveillance.  
Terminal digit preference has been described in many areas of medicine and 
epidemiology. “Age heaping” in national census data has been recognized for decades 
[32], and demonstrates clustering at digits ending in 0 or 5 in the West and multiples 
of 12 in China (corresponding to preferred years of the Chinese animal calendar) [33]. 
Medical practitioners seem equally affected by this bias, with studies from disparate 
areas such as blood pressure monitoring [18], neonatal birthweight [34], tumor size 
measurement [35], and emergency department waiting times [20] all reporting the 
phenomenon. 
The effect remains when small differences in measurement make a substantial 
difference to patient outcome, and may partly arise because of this clinical 
significance. For example, Hayes [19] described digit preference in the measurement 
of renal cancers, for which maximal diameter determines tumor stage (and hence 
treatment). Similarly, while biases in polyp diameter may extend to only a millimeter 
or so, they can affect subsequent management (i.e. referral for colonoscopy after CTC 
[11], or the timing and frequency of surveillance colonoscopy [6,7]). 
Whether polyps are most accurately measured by colonoscopy or CTC is not clear 
[36]. An in vivo study comparing CTC and several colonoscopic measurement 
techniques found that 2D CTC was the most reproducible between observers, 
although tended to record larger diameters than colonoscopy [13]. The technique used 
at endoscopy influences size measurement considerably, with comparison against 
open biopsy forceps being the least accurate in one study [37]. Nor is pathology a 
universal gold standard; even the measurement of polyp phantoms ex vivo (to mimic a 
polypectomy specimen in the pathology laboratory) is subject to considerable 
measurement error and poor reproducibility [38]. 
Irrespective of which technique is most accurate, current criteria for both referral for 
colonoscopy after CTC [11,24,25] and surveillance colonoscopy after polypectomy 
[6,7] are based on studies reporting the risk of histologically advanced neoplasia 
within polyps of various sizes (measured endoscopically and pathologically). As we 
have demonstrated that digit preference bias occurs for both colonoscopists and 
histopathologists, it is highly likely that this historical literature also incorporates digit 
preference. This might have the effect of erroneously placing many 9-mm polyps into 
the ≥10-mm category, which would (counter-intuitively) lower the proportion of 
lesions with advanced histology in both groups. As 9-mm polyps are, on average, the 
highest risk of the subcentimeter polyp group, moving them into the ≥10-mm category 
will tend to reduce the overall proportion of advanced histology in the remaining pool 
of subcentimeter polyps. Furthermore, as these same 9-mm polyps will, on average, 
be less likely to harbor advanced histology than most lesions ≥10 mm, their addition 
to the large polyp group will also reduce the proportion of advanced neoplasia here. In 
contrast, 11-mm polyps being “rounded down” to 10 mm would have no effect, as 
they would remain within the same size category. This so-called “Will Rogers 
phenomenon” (the apparently counter-intuitive reduction in risk for both groups) has 
been well-described for cancer stage migration [39]. The degree to which this affects 
rates of histologically advanced neoplasia in the historical literature is not clear, but 
our data suggest that such an effect is possible. 
The current study has some limitations. Polyp diameters recorded onto a central 
database or trial case report forms may not reflect the measurements given on the 
clinical endoscopy, radiology, or pathology report. It is possible that clinicians are 
more precise in their routine practice than when recording data for central analysis. 
Additionally, the technique of polyp measurement was not stipulated in detail, either 
for endoscopy or CTC, although arguably this reflects real-world practice most 
closely. Furthermore, the behavior of practitioners in both the BCSP and the RCTs, 
although broadly representative, may not generalize more widely. We were unable to 
retrieve data regarding individual practitioners, meaning we were unable to explore 
the possibility that the effect is underpinned by a subgroup of individuals who are 
particularly prone to such bias. We measured the effect of digit preference on the 
detection rate of polyps 10 mm, but this does not directly equate to a need for 
surveillance colonoscopy – this may be required in any case (e.g. because of 
multiplicity of subcentimeter adenomas [6,7], a situation that applied to 24% of 
patients in our cohort). Finally, statistical methods for estimating terminal digit 
preference are relatively under-developed, particularly when the true underlying 
distribution of the variable of interest is unknown. Accordingly, the techniques we 
applied here may not accurately model the genuine distribution of polyp diameters, 
potentially under- or over-estimating the magnitude of digit preference. The degree of 
uncertainty (i.e. the degree of under- or over-estimation) is unknown, due to the 
relative immaturity of the relevant statistical literature. We applied the methods to 
datasets ranging from 329 to >90 000 polyps and the methods may not be equally 
precise across these extremes. They also do not take into account the statistical 
clustering of multiple polyps within a single individual. This does not alter our 
primary conclusion that the digit preference bias phenomenon undoubtedly occurs, 
which is clear from simple inspection of the histograms of polyp diameter.  
In summary, we have shown that terminal digit preference occurs when endoscopists, 
radiologists, and pathologists are asked to measure the maximal diameter of colorectal 
polyps, for both symptomatic and screening patients. The magnitude of the effect was 
similar between the three specialities in terms of diagnostic yield at the ≥10-mm 
threshold. This bias may influence the number of patients entering polyp surveillance 
regimens and being referred for endoscopic excision, and will also affect comparisons 
of detection rates between tests in research studies. All relevant practitioners should 
be aware of this phenomenon when estimating the maximal diameter of colorectal 
polyps in order to reduce biases introduced by mis-classification. 
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Fig. 1 Endoscopist measurement of polyps in the screening program (BCSP). 
a  Histogram of observed endoscopically measured polyp diameters in the BCSP 
(with 95% confidence intervals). b,c  Number of re-allocated polyps grouped 
by terminal digit, expressed as a percentage of all re-allocated polyps, estimated 
by the Camarda method (b) and the Wang method (c).   
 
Fig. e2 Endoscopist measurement of adenomas and nonadenomas in the 
screening program, showing clusters for terminal digits of 0 and 5. 
a  Adenomas. b  Nonadenomas. Bars represent 95% confidence intervals. 
 
Fig. 3 Computed tomographic colonography (CTC) measurement of polyps 
in     the BCSP. a  Histogram of observed CTC-measured polyp diameters in 
the BCSP (with 95% confidence intervals). b,c  Number of re-allocated 
polyps grouped by terminal digit, expressed as a percentage of all re-allocated 
polyps, estimated by the Camarda method (b) and the Wang method (c).  
 
Fig. 4 Histopathological measurement of polyps in the screening program 
(ScrP). a  Histogram of observed histologically measured polyp diameters in 
the ScrP (with 95% confidence intervals). b,c  Number of re-allocated polyps 
grouped by terminal digit, expressed as a percentage of all re-allocated 
polyps, estimated by the Camarda method (b) and the Wang method (c).  
 
Fig. e5 Histopathological measurement of adenomas and nonadenomas in 
the screening program, showing clusters for terminal digits of 0 and 5. 
a  Adenomas. b  Nonadenomas. Bars represent 95% confidence intervals. 
 
Fig. 6 Endoscopic measurements of polyps in randomized controlled trials 
(RCTs). a  Histogram of observed endoscopically measured polyp diameters 
in the RCTs (with 95% confidence intervals). b,c  Number of re-allocated 
polyps grouped by terminal digit, expressed as a percentage of all re-allocated 
polyps, estimated by the Camarda method (b) and the Wang method (c). 
 
Fig. 7 Computed tomographic colonography (CTC) measurement of polyps 
in randomized controlled trials (RCTs). a  Histogram of observed CTC-
measured polyp diameters in RCTs (with 95% confidence intervals). 
b,c  Number of re-allocated polyps grouped by terminal digit, expressed as a 
percentage of all re-allocated polyps, estimated by the Camarda method (b) 
and the Wang method (c). 
 
Fig. 8 Histopathological measurement of polyps in randomized controlled 
trials (RCTs). a  Histogram of observed histologically measured polyp 
diameters in RCTs (with 95% confidence intervals). b,c  Number of re-
allocated polyps grouped by terminal digit, expressed as a percentage of all 
re-allocated polyps, estimated by the Camarda method (b) and the Wang 
method (c). 
 
Table 1  Observed and estimated (i.e. corrected for digit preference) number (percentage) of patients with a polyp ≥10 mm as their 
largest measured lesion, split by diagnostic modality, for both screening (BCSP) and trial (RCT) cases. The mean difference is the 
difference between the number of patients who were recorded to have at least one polyp ≥10 mm and the arithmetic mean of the 
estimate by the two smoothing methods.  
 
 BCSP cases RCT cases 
Endoscopy 
(n = 36 850) 
CTC (n = 892) Histopathology 
(n = 33 891) 
Endoscopy 
(n = 169) 
CTC 
(n = 333) 
Histopathology 
(n = 162) 
Observed, n (%) 15 952 (43.3) 483 (54.1) 14 282 (42.1) 81 (47.9) 192 (57.7) 102 (63.0) 
Camarda estimate, n (%) 15 223 (41.3) 463 (51.9) 13 653 (40.3) 73 (43.2) 194 (58.3) 98 (60.5) 
Wang estimate, n (%) 14 924 (40.5) 447 (50.1) 12 660 (37.4) 72 (42.6) 191 (57.4) 96 (59.3) 
Mean difference, n (%) –878.5 (–2.4) –28 (–3.1) –1125.5 (–3.3) –8.5 (–5.0) 0.5 (0.26) –5 (–3.1) 
CTC, computed tomographic colonography. 
